Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.67
+0.08001.74%
Pre-market: 4.670.00000.00%05:55 EDT
Volume:542.23K
Turnover:2.55M
Market Cap:146.12M
PE:-1.13
High:4.81
Open:4.58
Low:4.58
Close:4.59
52wk High:50.40
52wk Low:4.54
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.02
T/O Rate:2.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.67
PE(LYR):-1.64

Loading ...

Sangamo Therapeutics Delays Quarterly 10-Q Filing

TIPRANKS
·
Aug 18

Turn Therapeutics Raises $1.35M Through Private Placement

TIPRANKS
·
Aug 18

Akari Therapeutics Reaffirmed Buy as Analyst Keeps $27 Price Target on Advancing Trop2 ADC and Strengthened PH1 Platform

TIPRANKS
·
Aug 17

Summit Therapeutics falls -8.5%

TIPRANKS
·
Aug 17

Galera Therapeutics Inc trading halted, volatility trading pause

TIPRANKS
·
Aug 17

Allogene Therapeutics Price Target Maintained with a $6.00/Share by Citizens

Dow Jones
·
Aug 17

Press Release: Nuo Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 17

ADC Therapeutics price target lowered to $5 from $10 at Guggenheim

TIPRANKS
·
Aug 17

Cardiol Therapeutics price target raised to $10 from $8 at Canaccord

TIPRANKS
·
Aug 17

Tango Therapeutics price target raised to $35 from $32 at Guggenheim

TIPRANKS
·
Aug 17

Lenz Therapeutics price target lowered to $7 from $12 at Piper Sandler

TIPRANKS
·
Aug 17

ADC Therapeutics reports Q2 adjusted EPS (11c) vs. (25c) last year

TIPRANKS
·
Aug 17

Valerio Therapeutics Nears Signing of €30 Million Etherna Acquisition

TIPRANKS
·
Aug 17

HLS Therapeutics upgraded to Strong Buy from Outperform at Raymond James

TIPRANKS
·
Aug 17

Press Release: Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition

Dow Jones
·
Aug 17

Chimeric Therapeutics Halts Trading Ahead of CDH17 Trial Results

TIPRANKS
·
Aug 17

Quince Therapeutics participates in a conference call with Cantor Fitzgerald

TIPRANKS
·
Aug 17

Damora Therapeutics (DMRA) Starts CLARITY 101 Trial With Valuation Still In Focus

Simply Wall St.
·
Aug 17

Outlook Therapeutics reports Q3 EPS (15c), consensus (8c)

TIPRANKS
·
Aug 16

Revive Therapeutics Grants 15.5 Million Stock Options to Key Team Members

TIPRANKS
·
Aug 15